We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Controlling Quality of Radiotherapy Treatments

By HospiMedica staff writers
Posted on 04 Dec 2007
A portable, low-cost device can measure the ionizing radiation people are exposed during radiotherapy or other procedures involving radiation. More...


Researchers from the University of Granada (UGR, Spain) and Hospital Virgen de las Nieves (Granada, Spain) developed the new device to verify the exact dose of radiation administered to patients, as well as keeping historical records. The device does not require connection to an electrical source or a monitoring unit, and is made of low-cost and reusable electronic components. Furthermore, the device's design has metrological characteristics, which make certain that it performs correctly at high temperatures, and the detector's minuscule size can measure the radiation quickly in different areas of the body.

"The potential harm ionizing radiations can cause means that, in order to obtain clinical benefits and reduce the onset of unwanted adverse effects as much as possible, they must be used under strict quality control,” said lead author Manuel Vilches Pacheco, of the medical physics and radiology department at Hospital Virgen de las Nieves.

Portal imaging systems which facilitate accurate pre-treatment patient positioning prior to radiation treatment and provide ongoing verification of the accuracy of position during subsequent treatments, have greatly improved in the last five years and are widely used today. This is not the case for systems used for in vivo dose measurement, which has been limited to a few centers. This is largely due to the amount of effort required to place the device onto the patient, and as it interferes noticeably with the treatment, it can considerably modify the distribution of the administered dose.


Related Links:
University of Granada
Hospital Virgen de las Nieves

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Half Apron
Demi
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.